Roman Kriz, is CEO of Bene Meat Technologies, an ambitious and perhaps one of the most unconventional players in the cultivated-meat landscape. Bene Meat recently captured attention by using hamster-derived cell lines to produce affordable, scalable cultivated meat — a strategy Roman says is rooted in scientific pragmatism, regulatory clarity, and a relentless focus on cost reduction.
Roman breaks down why these specific cells are uniquely suited for industrial-scale production, how the company has navigated early EU regulatory pathways, and why Bene Meat is confident it will be selling cultivated meat in the European Union as early as next year.
Bene Meat plans to conduct human tastings in 2026, (not #hamster lines) a bold move that signals confidence not only in safety and functionality, but in the sensory potential of their product.
Roman offers transparent and frank look at the scientific decisions, business models, and unexpected breakthroughs that are bringing cultivated meat closer to everyday consumers.
Please like and subscribe - you can support the podcast here https://www.paypal.com/donate/?hosted_button_id=ABYF9L6UY3A5Y
